CytoDyn Market Cap

CytoDyn has a market cap or net worth of $247.72 million as of April 17, 2025. Its market cap has increased by 55.21% in one year.

Market Cap

247.72M

Enterprise Value

258.64M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.20

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 247.72M, an increase of 4,373.44%. That is a compound annual growth rate of 21.61%.

Market Cap History

Date	Market Cap	% Change
Apr 16, 2025	247.72M	83.99%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	3.21B	695.20%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SS Innovations International	1.84B
Endo Inc.	1.69B
Nika Pharmaceuticals	1.02B
Veradigm	695.27M
Elite Pharmaceuticals	454.28M
Glass House Brands	351.01M
Northwest Biotherapeutics	295.54M
BioStem Technologies	215.65M

Market Cap Rankings